论文信息 - Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin - 字舞流文

Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin

K. Dooley | J. Park | D. Haas | S. Koletar | F. Aweeka | A. Luetkemeyer | J. Bao | S. Murray | R. Savic | R. Allen | Yoninah S. Cramer | Florence Marzan | Deborah Sutherland